These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 829393)

  • 1. Growth hormone response to L-dopa in diabetes mellitus.
    Sekhuja V; Rastogi GK; Sialy R
    Acta Diabetol Lat; 1976; 13(5-6):242-9. PubMed ID: 829393
    [No Abstract]   [Full Text] [Related]  

  • 2. Growth hormone in insulin-treated diabetes mellitus.
    Sabeh G; Mendelsohn LV; Corredor DG; Sunder JH; Friedman LM; Morgan CR; Danowski TS
    Metabolism; 1969 Sep; 18(9):748-53. PubMed ID: 5343866
    [No Abstract]   [Full Text] [Related]  

  • 3. Suppression of growth hormone release by glucose administration in diabetic individuals.
    Bieler EU; Van Rooyen RJ; De Bruin EJ; Hoog JM
    S Afr Med J; 1973 Jun; 47(25):1117-9. PubMed ID: 4714709
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of oral alanine on blood beta-hydroxybutyrate and plasma glucose, insulin, free fatty acids, and growth hormone in normal and diabetic subjects.
    Genuth SM; Castro J
    Metabolism; 1974 Apr; 23(4):375-86. PubMed ID: 4206148
    [No Abstract]   [Full Text] [Related]  

  • 5. Reversal by insulin treatment of abnormal growth hormone pattern in newly diagnosed diabetes mellitus.
    Corrall RJ; Hunter WM; Campbell IW; Harrower AD; Duncan LJ; Clarke BF
    Acta Endocrinol (Copenh); 1974 Sep; 77(1):115-21. PubMed ID: 4408350
    [No Abstract]   [Full Text] [Related]  

  • 6. Glucagon and diabetes mellitus.
    Herlihy B
    Crit Care Nurse; 1983; 3(1):38-43. PubMed ID: 6402337
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of glucose on the glucagon response to L-dopa in normal and diabetic subjects.
    Klimes I; Vigas M; Jurcovicová J; Repceková D; Kolesár P
    Diabetes; 1978 Apr; 27(4):396-9. PubMed ID: 640244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of glucose on the growth hormone response to L-dopa in normal and diabetic subjects.
    Ajlouni K; Martinson DR; Hagen TC
    Diabetes; 1975 Jul; 24(7):633-6. PubMed ID: 1158029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of sleep-induced growth hormone secretion: no effect on diabetic control.
    Davidson MB; Peters AL
    Diabetes Care; 1990 Jul; 13(7):813-4. PubMed ID: 2257001
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of intravenous alanine on blood glucose, glucagon and growth hormone levels in diabetic children.
    Soltész G; Molnár D; Mestyán J
    Acta Paediatr Acad Sci Hung; 1982; 23(2):195-200. PubMed ID: 6814169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of somatostatin on the rise of growth hormone and glucagon secretion induced by arginine and L-dopa in diabetic patients.
    Hansen AP; Christensen SE; Lundbaek K
    Scand J Clin Lab Invest; 1975 May; 35(3):205-10. PubMed ID: 1153917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of hyperglycemia on the growth hormone response to L-dopa in diabetic subjects.
    Barbarino A; De Marinis L; Martino F
    J Endocrinol Invest; 1978 Jul; 1(3):259-61. PubMed ID: 756876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone responses to fructose in diabetes mellitus.
    Davidson MB; Steele RM
    Acta Endocrinol (Copenh); 1974 Mar; 75(3):497-502. PubMed ID: 4405990
    [No Abstract]   [Full Text] [Related]  

  • 14. Circadian rhythm of plasma growth hormone, cortisol and insulin in obese and diabetic children.
    Di Natale B; Devetta M; Rossi L; Garlaschi C; Caccamo A; Del Guercio MJ; Chiumello G
    Helv Paediatr Acta; 1973 Dec; 28(6):591-602. PubMed ID: 4785154
    [No Abstract]   [Full Text] [Related]  

  • 15. Re: A comparison of classification schemes for ketosis-prone diabetes.
    Nalini R; Maldonado M; Balasubramanyam A
    Nat Clin Pract Endocrinol Metab; 2007 Dec; 3(12):E1. PubMed ID: 18026157
    [No Abstract]   [Full Text] [Related]  

  • 16. Characteristics of growth hormone secretion in clinically stable diabetes.
    Merimee TJ; Fitzgerald CR; Gold LA; McCourt JP
    Diabetes; 1979 Apr; 28(4):308-12. PubMed ID: 437370
    [No Abstract]   [Full Text] [Related]  

  • 17. [Method of determination of somatotropin level in blood plasma with L-dopa loading in patients with diabetes mellitus complicated by microangiopathies].
    Babakhanov KhB
    Lab Delo; 1975; (10):605-7. PubMed ID: 54462
    [No Abstract]   [Full Text] [Related]  

  • 18. Maltose metabolism in diabetic state.
    Toyota T; Goto Y; Sato S; Shimojo Y; Takahashi K
    Tohoku J Exp Med; 1974 Sep; 114(1):61-9. PubMed ID: 4215175
    [No Abstract]   [Full Text] [Related]  

  • 19. Acid-base status in nonketotic diabetics.
    Ipbüger A; Svendsen PA
    Scand J Clin Lab Invest; 1974 Dec; 34(4):343-8. PubMed ID: 4218660
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma growth hormone levels after lunch in diabetic and non-diabetic subjects.
    Tchobroutsky G
    Acta Endocrinol (Copenh); 1973 Sep; 74(1):67-78. PubMed ID: 4800844
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.